Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Glucose Transporter Type 1 Deficiency Syndrome
NCT02968953: Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome	No Longer Available	N/A		US	Triheptanoin, UX007	Jerry Vockley, MD, PhD, Ultragenyx Pharmaceutical Inc	Glucose Transporter 1 Deficiency Syndrome
NCT02018302: Post Study Continuation of C7 for G1D	No Longer Available	N/A		US	Triheptanoin, C7 oil, Heptanoate, heptanoic acid	Juan Pascual	Glut1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome